The U.S. Food and Drug Administration regulates which adult stemcell techniques are allowed to go into clinical trials and sets the requirements for more routine use.
Regulatory agencies, such as the U.S. Food and Drug Administration and the European Medicines Agency, are closely scrutinizing stemcell therapies they are asked to review and approve.